Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Marjolijn J. P. van Wanrooy"'
Autor:
Michael G. G. Rodgers, Jan G. Zijlstra, Lambert F.R. Span, Tjip S. van der Werf, Jos G. W. Kosterink, Jan-Willem C. Alffenaar, Marjolijn J. P. van Wanrooy, Donald R. A. Uges
Publikováno v:
Therapeutic Drug Monitoring, 38(3), 313-318. LIPPINCOTT WILLIAMS & WILKINS
BACKGROUND: Routine therapeutic drug monitoring of voriconazole appears to be beneficial. This study investigated the therapeutic drug monitoring practices in intensive care to derive possible recommendations for improvement.METHODS: A retrospective
Autor:
Jos G. W. Kosterink, Charlie H. S. Brouwers, Marjolijn J. P. van Wanrooy, Donald R. A. Uges, Kim C. M. van der Elst, Lambert F.R. Span, Edwin R. van den Heuvel, Jan-Willem C. Alffenaar, Tjip S. van der Werf
Publikováno v:
Therapeutic Drug Monitoring, 37(6), 766-771. LIPPINCOTT WILLIAMS & WILKINS
BACKGROUND: Posaconazole exposure seems to be subtherapeutic in some patients with invasive fungal disease. Due to the pharmacokinetic variability of posaconazole, therapeutic drug monitoring may help to optimize the efficacy of this antifungal drug.
Autor:
Donald R. A. Uges, Marjolijn J. P. van Wanrooy, Michael G. G. Rodgers, Jos G. W. Kosterink, Tjip S. van der Werf, Johannes H. Proost, Jan G. Zijlstra, Jan-Willem C. Alffenaar
Publikováno v:
Antimicrobial Agents and Chemotherapy, 59(2), 1177-1181. AMER SOC MICROBIOLOGY
Efficacy of anidulafungin is driven by the area under the concentration-time curve (AUC)/MIC ratio. Determination of the anidulafungin AUC along with MIC values can therefore be useful. Since obtaining a full concentration-time curve to determine an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::654fdfed85bde3acd4c63276996847ee
https://research.rug.nl/en/publications/5a5c9067-86cc-495f-83fd-3bdc1c714bed
https://research.rug.nl/en/publications/5a5c9067-86cc-495f-83fd-3bdc1c714bed
Autor:
Marjolijn J. P. van Wanrooy, Edwin R. van den Heuvel, Jos G. W. Kosterink, Michael G. G. Rodgers, Tjip S. van der Werf, Lambert F.R. Span, Jan-Willem C. Alffenaar, Donald R. A. Uges
Publikováno v:
Antimicrobial Agents and Chemotherapy, 58(12), 7098-7101. AMER SOC MICROBIOLOGY
Voriconazole concentrations display a large variability, which cannot completely be explained by known factors. Inflammation may be a contributing factor, as inflammatory stimuli can change the activities and expression levels of cytochrome P450 isoe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec23180a38ff162b5f0930dd1dbd2882
https://research.rug.nl/en/publications/04041055-f2aa-421f-9bb4-1403fa15e35b
https://research.rug.nl/en/publications/04041055-f2aa-421f-9bb4-1403fa15e35b
Autor:
Michael G. G. Rodgers, Jan G. Zijlstra, Jan-Willem C. Alffenaar, Jan P. Arends, Donald R. A. Uges, Jos G. W. Kosterink, Marjolijn J. P. van Wanrooy, Tjip S. van der Werf
Publikováno v:
Antimicrobial Agents and Chemotherapy, 58(1), 304-308. AMER SOC MICROBIOLOGY
The efficacy of anidulafungin is driven by the area under the concentration-time curve (AUC)/MIC ratio. Patients in intensive care may be at risk for underexposure. In critically ill patients with an invasive Candida infection, the anidulafungin expo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be989726e8ffcbc801c0f945be6a63b7
https://research.rug.nl/en/publications/87cb6ce8-bf63-43d8-9d13-bb312869efb8
https://research.rug.nl/en/publications/87cb6ce8-bf63-43d8-9d13-bb312869efb8
Autor:
Donald R. A. Uges, Jan-Willem C. Alffenaar, Kai van Hateren, Carli M. Wilmer, Marjolijn J. P. van Wanrooy, A. Mireille A. Wessels, Ben Greijdanus, Riaaz N. Santoe, Kim C. M. van der Elst
Publikováno v:
Therapeutic Drug Monitoring, 35, 6, pp. 778-84
Therapeutic Drug Monitoring, 35(6), 778-784. LIPPINCOTT WILLIAMS & WILKINS
Therapeutic Drug Monitoring, 35, 778-84
Therapeutic Drug Monitoring, 35(6), 778-784. LIPPINCOTT WILLIAMS & WILKINS
Therapeutic Drug Monitoring, 35, 778-84
Item does not contain fulltext INTRODUCTION: Echinocandins are a valuable addition for the treatment of invasive fungal infections, as they are efficacious, demonstrate low toxicity, and have limited drug-drug interactions. In specific clinical situa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::694053816387249a1cbb9677d2de3ba5
https://doi.org/10.1097/FTD.0b013e31829591a7
https://doi.org/10.1097/FTD.0b013e31829591a7
Autor:
van Wanrooy, Marjolijn J. P., Rodgers, Michael G. G., Span, Lambert F. R., Zijlstra, Jan G., Uges, Donald R. A., Kosterink, Jos G. W., van der Werf, Tjip S., Alffenaar, Jan-Willem C.
Publikováno v:
Therapeutic Drug Monitoring; Jun2016, Vol. 38 Issue 3, p313-318, 6p
Subtherapeutic Posaconazole Exposure and Treatment Outcome in Patients With Invasive Fungal Disease.
Autor:
van der Elst, Kim C. M., Brouwers, Charlie H. S., van den Heuvel, Edwin R., van Wanrooy, Marjolijn J. P., Uges, Donald R. A., van der Werf, Tjip S., Kosterink, Jos G. W., Span, Lambert F. R., Alffenaar, Jan-Willem C.
Publikováno v:
Therapeutic Drug Monitoring; Dec2015, Vol. 37 Issue 6, p766-771, 6p
Autor:
Van Wanrooy, Marjolijn J. P., Santoe, Riaaz N., Van Der Elst, Kim C. M., Wilmer, Carli M., Van Hateren, Kai, Wessels, A. Mireille A., Greijdanus, Ben, Alffenaar, Jan-Willem C., Uges, Donald R. A.
Publikováno v:
Therapeutic Drug Monitoring; Dec2013, Vol. 35 Issue 6, p778-784, 7p